经济划算
生产更多
放射性核素

Two IBA Rhodotron®TT 300-HE (High Energy) electron beam accelerators were rigged in Beloit, Wisconsin. The accelerators are critical components in a first-of-its-kind commercial-scale process to produce Mo-99, the parent radioisotope of technetium-99m, the most widely used medical imaging radioisotope, informing healthcare decisions for approximately 40,000 U.S. patients daily. We are proud to be part of this project !

Ever since IBA launched its first cyclotron in 1986, we have been on a mission to innovate and push the boundaries of technology further. Our goal? Offer you the best technology and services, while ensuring a high return on investment and low cost of ownership. We are pleased to invite you to a breakthrough announcement that’s a significant jump into the future. We’ll be holding an online event and will be honoured if you would attend.  When? June 10th 2021 at 3.00 pm CET  Register

The cyclotron for the Quantum Health Group project is now in its final position at Royal Darwin Hospital! This project includes the integration of multiple pieces of equipment such as hotcells and Synthera®+ Synthesis modules for the production of F-18 and Ga-68 compounds for patient diagnosis.   Congratulations to Jonathan Yilmaz, Tiffany Chiew, Philip Greatbatch, Jacqueline Cawthray and all the people involved in this project

The cyclotron was placed into its final position at the PSU ! The project offered jointly by Philips and IBA includes the integration of the cyclotron, the cameras, all necessary lab equipment,… as well as the facility layout and design for the establishment of a cutting edge GMP radiopharmaceutical production centers. The new PET center will produce various molecules including FDG and Ga-PSMA on the Synthera®+ platform but also N-13, C-11 and O-15 compounds!